1. Home
  2. VNRX vs WCT Comparison

VNRX vs WCT Comparison

Compare VNRX & WCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VNRX
  • WCT
  • Stock Information
  • Founded
  • VNRX N/A
  • WCT 2012
  • Country
  • VNRX United States
  • WCT Hong Kong
  • Employees
  • VNRX N/A
  • WCT N/A
  • Industry
  • VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • WCT
  • Sector
  • VNRX Health Care
  • WCT
  • Exchange
  • VNRX Nasdaq
  • WCT NYSE
  • Market Cap
  • VNRX 67.2M
  • WCT 74.2M
  • IPO Year
  • VNRX N/A
  • WCT 2024
  • Fundamental
  • Price
  • VNRX $0.66
  • WCT $1.04
  • Analyst Decision
  • VNRX Strong Buy
  • WCT
  • Analyst Count
  • VNRX 4
  • WCT 0
  • Target Price
  • VNRX $4.17
  • WCT N/A
  • AVG Volume (30 Days)
  • VNRX 577.3K
  • WCT 2.3M
  • Earning Date
  • VNRX 11-14-2024
  • WCT 02-15-2025
  • Dividend Yield
  • VNRX N/A
  • WCT N/A
  • EPS Growth
  • VNRX N/A
  • WCT 20.11
  • EPS
  • VNRX N/A
  • WCT 0.05
  • Revenue
  • VNRX $1,285,827.00
  • WCT $2,370,163.00
  • Revenue This Year
  • VNRX $180.66
  • WCT N/A
  • Revenue Next Year
  • VNRX $558.69
  • WCT N/A
  • P/E Ratio
  • VNRX N/A
  • WCT $21.17
  • Revenue Growth
  • VNRX 97.50
  • WCT 49.00
  • 52 Week Low
  • VNRX $0.43
  • WCT $0.94
  • 52 Week High
  • VNRX $1.23
  • WCT $9.36
  • Technical
  • Relative Strength Index (RSI)
  • VNRX 52.35
  • WCT N/A
  • Support Level
  • VNRX $0.57
  • WCT N/A
  • Resistance Level
  • VNRX $0.68
  • WCT N/A
  • Average True Range (ATR)
  • VNRX 0.08
  • WCT 0.00
  • MACD
  • VNRX 0.00
  • WCT 0.00
  • Stochastic Oscillator
  • VNRX 82.35
  • WCT 0.00

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

About WCT WELLCHANGE HOLDINGS COMPANY LIMITED

Wellchange Holdings Co Ltd is an enterprise software solution services provider. It provides software solutions, cloud-based software-as-a-service ("SaaS") platforms, and "white-label" software design and development services.

Share on Social Networks: